BibTex RIS Cite

Palliative radiotherapy for malign melanoma: a case report

Year 2006, Volume: 21 Issue: 3, 151 - 155, 01.04.2006

Vuslet Yürüt Çaloğlu Murat Çaloğlu Füsun Tokatlı Zafer Koçak Ruşen Coşar Alas Kamuran İbiş Hakan Karagöl Ercüment Ünlü Cem Uzal

Abstract

Malignant melanoma is a skin cancer with poor prognosis. Historically melanoma has been thought of as a relatively radioresistant tumour. Nowadays, radiation delivered according to hypofractionated schedule is the most used, although there are few data confirm that this schedule improves the therapeutic impact. We report a case, with stage IV malignant melanoma, whose tumoral bleeding was palliated successfully giving 20 Gy external radiotherapy in 5 fractionations.

Keywords

Melanoma Aged Male Radiotherapy Magnetic Resonance Imaging Palliative Care

References

  • 1. Apayd›n F. Anatomik özellikler ve klinik gidifl. In: Esassolak M, editor. Bafl-boyun kanserleri. ‹stanbul: Nobel T›p Kitapevi; 2003. p. 605-19.
  • 2. Bastiaannet E, Beukema JC, Hoekstra HJ. Radiation therapy following lymph node dissection in melanoma patients: treatment, outcome and complications. Cancer Treat Rev 2005;31(1):18-26.
  • 3. Ang KK, Byers RM, Peters LJ, Maor MH, Wendt CD, Morrison WH, et al. Regional radiotherapy as adjuvant treatment for head and neck malignant melanoma. Preliminary results. Arch Otolaryngol Head Neck Surg 1990;116(2):169-72.
  • 4. Barranco SC, Romsdahl MM, Humphrey RM. The radiation response of human malignant melanoma cells grown in vitro. Cancer Res 1971;31(6):830-3.
  • 5. Harwood AR. Conventional fractionated radiotherapy for 51 patients with lentigo maligna and lentigo maligna melanoma. Int J Radiat Oncol Biol Phys 1983;9(7):1019-21.
  • 6. Habermalz HJ. Irradiation of malignant melanoma: experience in the past and present. Int J Radiat Oncol Biol Phys 1981;7(1):131-3.
  • 7. Sause WT, Cooper JS, Rush S, Ago CT, Cosmatos D, Coughlin CT, et al. Fraction size in external beam radiation therapy in the treatment of melanoma. Int J Radiat Oncol Biol Phys 1991;20(3):429-32.
  • 8. Bentzen SM, Overgaard J, Thames HD, Overgaard M, Vejby Hansen P, von der Maase H, et al. Clinical radiobiology of malignant melanoma. Radiother Oncol 1989;16(3):169-82.
  • 9. Trott KR. The optimal radiation dose per fraction for the treatment of malignant melanomas. Int J Radiat Oncol Biol Phys 1991;20(4):905-7.
  • 10.Johanson CR, Harwood AR, Cummings BJ, Quirt I. 0- 7-21 radiotherapy in nodular melanoma. Cancer 1983;51(2):226-32.
  • 11. Burmeister BH, Smithers BM, Poulsen M, McLeod GR, Bryant G, Tripcony L, et al. Radiation therapy for nodal disease in malignant melanoma. World J Surg 1995;19(3):369-71.
  • 12. Overgaard J. The role of radiotherapy in recurrent and metastatic malignant melanoma: a clinical radiobiological study. Int J Radiat Oncol Biol Phys 1986;12:867-72.

Bir olgu nedeniyle malign melanomlarda palyatif radyoterapi

Year 2006, Volume: 21 Issue: 3, 151 - 155, 01.04.2006

Vuslet Yürüt Çaloğlu Murat Çaloğlu Füsun Tokatlı Zafer Koçak Ruşen Coşar Alas Kamuran İbiş Hakan Karagöl Ercüment Ünlü Cem Uzal

Abstract

Malign melanom oldukça kötü prognozlu bir cilt kanseri türüdür. Genel olarak radyorezistan olduğu düşünülmektedir. Günümüzde bu hastalığın tedavisinde sıklıkla hipofraksiyone radyoterapi şemaları kullanılmakla birlikte, standart tedavi şemasını belirleyebilecek literatür çalışmaları bulunmamaktadır. Bu yazıda, evre IV malign melanom tanılı, kanaması 5 fraksiyonda toplam 20 Gy eksternal radyoterapi ile etkin ve güvenli bir şekilde tedavi edilen bir olgu sunuldu.

Keywords

Malign melanom melanom/patoloji/radyoterapi neoplazm multipl birincil/patoloji/radyoterapi.

References

  • 1. Apayd›n F. Anatomik özellikler ve klinik gidifl. In: Esassolak M, editor. Bafl-boyun kanserleri. ‹stanbul: Nobel T›p Kitapevi; 2003. p. 605-19.
  • 2. Bastiaannet E, Beukema JC, Hoekstra HJ. Radiation therapy following lymph node dissection in melanoma patients: treatment, outcome and complications. Cancer Treat Rev 2005;31(1):18-26.
  • 3. Ang KK, Byers RM, Peters LJ, Maor MH, Wendt CD, Morrison WH, et al. Regional radiotherapy as adjuvant treatment for head and neck malignant melanoma. Preliminary results. Arch Otolaryngol Head Neck Surg 1990;116(2):169-72.
  • 4. Barranco SC, Romsdahl MM, Humphrey RM. The radiation response of human malignant melanoma cells grown in vitro. Cancer Res 1971;31(6):830-3.
  • 5. Harwood AR. Conventional fractionated radiotherapy for 51 patients with lentigo maligna and lentigo maligna melanoma. Int J Radiat Oncol Biol Phys 1983;9(7):1019-21.
  • 6. Habermalz HJ. Irradiation of malignant melanoma: experience in the past and present. Int J Radiat Oncol Biol Phys 1981;7(1):131-3.
  • 7. Sause WT, Cooper JS, Rush S, Ago CT, Cosmatos D, Coughlin CT, et al. Fraction size in external beam radiation therapy in the treatment of melanoma. Int J Radiat Oncol Biol Phys 1991;20(3):429-32.
  • 8. Bentzen SM, Overgaard J, Thames HD, Overgaard M, Vejby Hansen P, von der Maase H, et al. Clinical radiobiology of malignant melanoma. Radiother Oncol 1989;16(3):169-82.
  • 9. Trott KR. The optimal radiation dose per fraction for the treatment of malignant melanomas. Int J Radiat Oncol Biol Phys 1991;20(4):905-7.
  • 10.Johanson CR, Harwood AR, Cummings BJ, Quirt I. 0- 7-21 radiotherapy in nodular melanoma. Cancer 1983;51(2):226-32.
  • 11. Burmeister BH, Smithers BM, Poulsen M, McLeod GR, Bryant G, Tripcony L, et al. Radiation therapy for nodal disease in malignant melanoma. World J Surg 1995;19(3):369-71.
  • 12. Overgaard J. The role of radiotherapy in recurrent and metastatic malignant melanoma: a clinical radiobiological study. Int J Radiat Oncol Biol Phys 1986;12:867-72.
There are 12 citations in total.

Details

Primary Language Turkish
Journal Section Articles
Authors

Vuslet Yürüt Çaloğlu This is me

Murat Çaloğlu This is me

Füsun Tokatlı This is me

Zafer Koçak This is me

Ruşen Coşar Alas This is me

Kamuran İbiş This is me

Hakan Karagöl This is me

Ercüment Ünlü This is me

Cem Uzal This is me

Publication Date April 1, 2006
Published in Issue Year 2006 Volume: 21 Issue: 3

Cite

APA Çaloğlu, V. Y., Çaloğlu, M., Tokatlı, F., Koçak, Z., et al. (2006). Bir olgu nedeniyle malign melanomlarda palyatif radyoterapi. Türk Onkoloji Dergisi, 21(3), 151-155.
AMA Çaloğlu VY, Çaloğlu M, Tokatlı F, Koçak Z, Alas RC, İbiş K, Karagöl H, Ünlü E, Uzal C. Bir olgu nedeniyle malign melanomlarda palyatif radyoterapi. Türk Onkoloji Dergisi. April 2006;21(3):151-155.
Chicago Çaloğlu, Vuslet Yürüt, Murat Çaloğlu, Füsun Tokatlı, Zafer Koçak, Ruşen Coşar Alas, Kamuran İbiş, Hakan Karagöl, Ercüment Ünlü, and Cem Uzal. “Bir Olgu Nedeniyle Malign Melanomlarda Palyatif Radyoterapi”. Türk Onkoloji Dergisi 21, no. 3 (April 2006): 151-55.
EndNote Çaloğlu VY, Çaloğlu M, Tokatlı F, Koçak Z, Alas RC, İbiş K, Karagöl H, Ünlü E, Uzal C (April 1, 2006) Bir olgu nedeniyle malign melanomlarda palyatif radyoterapi. Türk Onkoloji Dergisi 21 3 151–155.
IEEE V. Y. Çaloğlu, M. Çaloğlu, F. Tokatlı, Z. Koçak, R. C. Alas, K. İbiş, H. Karagöl, E. Ünlü, and C. Uzal, “Bir olgu nedeniyle malign melanomlarda palyatif radyoterapi”, Türk Onkoloji Dergisi, vol. 21, no. 3, pp. 151–155, 2006.
ISNAD Çaloğlu, Vuslet Yürüt et al. “Bir Olgu Nedeniyle Malign Melanomlarda Palyatif Radyoterapi”. Türk Onkoloji Dergisi 21/3 (April 2006), 151-155.
JAMA Çaloğlu VY, Çaloğlu M, Tokatlı F, Koçak Z, Alas RC, İbiş K, Karagöl H, Ünlü E, Uzal C. Bir olgu nedeniyle malign melanomlarda palyatif radyoterapi. Türk Onkoloji Dergisi. 2006;21:151–155.
MLA Çaloğlu, Vuslet Yürüt et al. “Bir Olgu Nedeniyle Malign Melanomlarda Palyatif Radyoterapi”. Türk Onkoloji Dergisi, vol. 21, no. 3, 2006, pp. 151-5.
Vancouver Çaloğlu VY, Çaloğlu M, Tokatlı F, Koçak Z, Alas RC, İbiş K, Karagöl H, Ünlü E, Uzal C. Bir olgu nedeniyle malign melanomlarda palyatif radyoterapi. Türk Onkoloji Dergisi. 2006;21(3):151-5.